Researchers from the University of East Anglia have helped to carry out the first comprehensive survey of viruses found within different types of cancer. An international team systematically investigated the DNA found within more than 2,600 tumour samples from patients with 38 different types of cancer. They discovered traces of viruses in 13 per cent […]
Read More… from First Comprehensive Survey of Virus DNA Found Within Cancer Cells
Sarcoma UK is calling on the National Institute for Health and Care Excellence (NICE), NHS England, and pharmaceutical companies to have flexibility so that cancer patients in England with few treatment options can access the latest treatments as soon as possible. National bone and soft tissue cancer charity, Sarcoma UK, was disappointed to see that […]
Read More… from Calls For Flexibility To All ‘Game Changing’ Cancer Treatments
‘- Aggressive stomach and gullet cancers evolve escape routes under selective pressure from immune system – Findings underline importance of cancer evolution, and could help optimise immunotherapy Aggressive, highly mutated cancers evolve escape routes in response to immune attacks in an ‘evolutionary arms race’ between cancer and the immune system, a new study reports. Gullet […]
Read More… from Cancers Engaged in Evolutionary Arms Race with Immune System
· Only 28 per cent of people believe cancers can be controlled long term – yet the average patient now lives more than 10 years from diagnosis · Just 26 per cent of people think we are making major progress against cancer, even though average survival time from cancer has approximately doubled in a decade […]
Read More… from Cancer Research Offers More Hope Than People Think
Sarcoma UK is disappointed to see that life extending cancer drug trabectedin (Yondelis) will not be made available routinely on the NHS to sarcoma patients in Scotland. Trabectedin, a chemotherapy drug which has been routinely available in the rest of the UK for over a decade, has been denied approval for regular use in Scotland […]
Read More… from Life Extending Cancer Drug will not be made Available to all Patients in Scotland
A comprehensive new report launched on Tuesday 26th November 2019 and commissioned by the charity Sarcoma UK reveals how this little-known and commonly misunderstood cancer has a devastating impact on its patients and their families, from diagnosis through to treatment. And yet, according to a YouGov poll commissioned by the charity, 75% of people “do […]
Researchers at Queen’s University Belfast have received the first scientific research grant from MDS UK to improve treatment for Myelodysplastic Syndromes (MDS), a type of bone marrow cancer. Myelodysplastic Syndromes (MDS) are a form of bone marrow cancer whereby the bone marrow gradually fails to produce mature healthy cells. In some patients, MDS can progress […]
Immunotherapy pembrolizumab keeps some patients alive for three years or more Pembrolizumab either used alone or in combination with chemotherapy was more effective than a standard cocktail of chemotherapy drugs in a study involving nearly 900 patients. For patients who responded to treatment, the duration of response was five times longer for pembrolizumab alone than […]
Read More… from Immunotherapy Backed as Standard First-line Treatment for Head and Neck Cancer
If Bal Gill had not chosen to visit the Camera Obscura and World of Illusions at Edinburgh’s Royal Mile earlier this year, there’s a good chance she would be facing a death sentence instead. The tourist attraction in the Scottish capital is a popular destination for tourists to the city and offers, among other things, […]
It is a while since I have written a blog. My disease has been stable for just over a year now and I have focused on living life as normally as possible, contributing where I can through work, and making sure to do some fun things in the meantime. Highlights include being at Lords for […]